KS
Ketan Sablok
About Ketan Sablok
Data last updated:
Ketan Sablok has 9 years in corporate governance. Holds Cfo role. Currently with 2 companies, including Rossari Biotech Limited and Romakk Chemicals Private Limited. Formerly with 4 companies, such as Convergence Chemicals Private Limited and Sulakshana Securities Limited. Engaged in Technology, General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹2,117 Cr; the largest is Rossari Biotech Limited at ₹2,084 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rossari Biotech Limited L24100MH2009PLC194818 | Cfo | 01 May 2023 | 2009 | ₹2,084 Cr (FY 2025) | Active |
 Romakk Chemicals Private Limited U24299MH2021PTC357112 | Cfo | 01 Aug 2023 | 2021 | ₹32.35 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Convergence Chemicals Private Limited U24100MH2014PTC373507 | Director | 12 Jul 2018 | 2014 | ₹120 Cr (FY 2021) | Amalgamated |
 Sulakshana Securities Limited U67120MH1995PLC085469 | Director | 03 Nov 2016 | 1995 | ₹6.07 Cr (FY 2025) | Active |
| Navin Fluorine Advanced Sciences Limited U24297MH2020PLC337262 | Director | 06 Feb 2020 | 2020 | ₹842 Cr (FY 2025) | Active |
 Navin Fluorine International Limited L24110MH1998PLC115499 | Cfo | 16 Jun 2018 | 1998 | ₹2,393 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ketan Sablok
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ketan Sablok
Ketan Sablok has 9 years in corporate governance. Holds Cfo role. Currently with 2 companies, including Rossari Biotech Limited and Romakk Chemicals Private Limited. Formerly with 4 companies, such as Convergence Chemicals Private Limited and Sulakshana Securities Limited. Engaged in Technology, General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹2,117 Cr; the largest is Rossari Biotech Limited at ₹2,084 Cr (FY 2025).
Ketan Sablok is associated with 2 companies as Cfo, including Rossari Biotech Limited (₹2,084 Cr), Romakk Chemicals Private Limited (₹32.35 Cr).
Ketan Sablok has expertise in Technology, General Business.
Ketan Sablok has 9 years in corporate governance.
By reported revenue, the largest current company of Ketan Sablok is Rossari Biotech Limited, with revenue of ₹2,084 Cr (FY 2025).
The 2 current companies of Ketan Sablok that report revenue have a combined latest revenue of ₹2,117 Cr.
Ketan Sablok currently holds positions at 2 companies: Rossari Biotech Limited (₹2,084 Cr), Romakk Chemicals Private Limited (₹32.35 Cr).